RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial
JF MD Conference Express
YR 2006
FD SAGE Publications
VO 6
IS 5
SP 21
OP 21
DO 10.1177/155989770600600511
UL http://mdc.sagepub.com/content/6/5/21.abstract
AB The Myoblast Autologous Grafting in Ischemic Cardiomyopathy [MAGIC] Trial examined the safety and efficacy of autologous skeletal myoblast cell therapy for improving local or global cardiac contractility in patients with ischemic heart failure. This is the first multi-center, randomized, double blind and placebo controlled trial of skeletal myoblast implantation and one that is designed with the power sufficient to determine whether autologous grafting is a viable solution for ischemic cardiomyopathy.